¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed receptive-expressive language disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® affective disorder ÇÑ±Û Á¤µ¿Àå¾Ö
¼³¸í   
  ÁַΠ±âºÐÀÇ Àå¾Ö°¡ ÁÖÃàÀÌ µÇ´Â ÀÏ·ÃÀÇ Á¤½ÅÀå¾ÖÀÌ´Ù. ÀÌ º´ÀÇ ¹üÁÖ¿¡´Â(¿ì¿ïº´£­Áö¼ÓÀûÀ¸·Î ¿ì¿ïÇÑ ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ ³ªÅ¸³ª´Â º´), (Á¶º´£­Áö¼ÓÀûÀ¸·Î µé¶á ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ °è¼ÓµÇ´Â º´) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® psychiatric disorder(s) ÇÑ±Û Á¤½ÅÁúȯ
¼³¸í   
  Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ Àִ ÁúȯÀ¸·Î, Á¤½ÅºÐ¿­º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
¿µ¹® dissociative disorder ÇÑ±Û ÇØ¸®Àå¾Ö
¼³¸í   
  ÀǽÄ, µ¿ÀÛ, È¤Àº ÁÖü¼º µîÀÇ ÀΰÝÀÇ Á¤»óÀûÀΠÅëÇÕ±â´É¿¡ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ Çϳª, ¶Ç´Â ±× ÀÌ»óÀÇ ±â´ÉÀÇ ¾î´À ºÎºÐÀÌ »ó½ÇµÇ´Â Á¤½ÅÁúȯÀ» Çظ®¼º Àå¾Ö¶ó°í ÇÑ´Ù. ÀÌ Áúȯ¿¡ ¼ÓÇϴ ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ½ÉÀμº±â¾ï»ó½ÇÁõ(psychogenic amnesia), ´ÙÁßÀΰÝ(multiple personality), µÐÁÖ(fugue) µîÀÌ ÀÖ´Ù. ½ÉÀμº ±â¾ï»ó½ÇÁõÀ̶õ Á¤½ÅÀûÀΠÅëÇÕ±â´É Áß¿¡¼­ Æ¯È÷ ÀǽÄÀÇ ±Þ°ÝÇϰí ÀϽÃÀûÀΠº¯È­°¡ ÀϾ¼­ ³úÀÇ Àå¾Ö¾øÀÌ °ú°ÅÀÇ ÀÏÀ» ±â¾ïÇÏÁö ¸øÇϴ °ÍÀ» ¸»ÇÑ´Ù. ´ÙÁßÀΰÝÀ̶õ ÇÑ °¡Áö ÀÌ»óÀÇ ÀΰÝÀÌ »ç¶÷¿¡°Ô Á¸ÀçÇϴ °ÍÀ¸·Î Æ¯Á¤ÇÑ ÀΰÝÀº ÀÏÁ¤ ±â°£µ¿¾È ±× »ç¶÷À» Áö¹èÇÏ°í ±× Àΰݠ°¢°¢Àº ±× ³ª¸§ÀǠü°è¸¦ °¡Áö°í Àΰ£°ü°è¸¦ Çü¼ºÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù. µÐÁÖ¶õ ÀÚ½ÅÀÇ ÁÖü¿¡ ´ëÇÑ ±â¾ïÀ» »ó½ÇÇÏ°í »õ·Î¿î ÁÖü¼ºÀ» °¡Áö°í °¡Á¤À̳ª Á÷ÀåÀ» ¶°³ª¼­ ¿¹Á¤¿¡ ¾ø´ø ¿©ÇàÀ» °©ÀÛ½º·´°Ô Çϴ °ÍÀ¸·Î ´ë°³ Åë»óÀûÀΠ»óȲ¿¡¼­´Â °ÅÀÇ ÀϾÁö ¾Ê°í Àü½Ã, ÃµÀçÁöº¯¿¡¼­ ÀÚÁÖ ÀÖ°í µÐÁÖ¿¡¼­ÀǠȸº¹Àº ±ÞÀÛ½º·´°Ô ÀϾ°í Àç¹ßÀº °ÅÀÇ ¾ø´Ù. Çظ®¼º Àå¾ÖÀÇ ´ëºÎºÐÀº È¸º¹ÀÌ µÉ °æ¿ì¿¡´Â ¹ßº´±â°£ Áß¿¡ ÀÖ¾ú´ø ÀÏÀ» ±â¾ïÇØ ³»Áö ¸øÇϴ °ÍÀÌ ´ëºÎºÐÀÌ´Ù.
¿µ¹® behavior disorder ÇÑ±Û ÇൿÀå¾Ö
¼³¸í   
  Á¤½ÅÀå¾Ö¸¦ °¡¸®Å°´Âµ¥ »ç¿ëµÇ´Â ¿ë¾î·Î¼­, Æ¯È÷ ÁöÀû, °¨Á¤Àû, ÇൿÀû Á¤½ÅÀå¾ÖÀ̸ç, ±âÁúÀû Àå¾Ö°¡ À־ »ý±â´Â °ÍÀº ¾Æ´Ï´Ù. Áö¼ÓÀûÀ¸·Î Å¸ÀÎÀÇ ±Ç¸®¸¦ Ä§¹üÇϰųª ³ªÀÌ¿¡ °É¸ÂÁö ¾Ê°Ô »çȸÀû ±Ô¹üÀ» ¾î±â´Â ÇൿÀÌ ³ªÅ¸³ª´Â Àå¾Ö·Î¼­, µµ½Ã¿¡¼­ ´õ ¸¹ÀÌ ³ªÅ¸³ª´Â °æÇâÀÌ ÀÖ´Ù. Á¤½ÅºÐ¼®ÇÐÀûÀΠ°ßÇØ¿¡ ÀÇÇϸ頵µ´öÀû ÃÊÀھư¡ ¼ºÀåÇÏÁö ¸øÇÏ¿© ³ªÅ¸³ª°Å³ª ºÎ¸ðÀÇ ¹«ÀǽÄÀûÀÌ°í ¹Ý»çȸÀû Ã浿ÀÌ ¾î¸°ÀÌ¿¡°Ô Àü´ÞµÇ¾î ÇൿȭÇϴ °ÍÀ̶ó°í ÇÑ´Ù. °¡Á¤È¯°æÀû ¿øÀÎÀ¸·Î´Â °á¼Õ°¡Á¤, ºÎ¸ðÀÇ °¥µî, ¾ËÄڿàÁßµ¶, ¾à¹°³²¿ë, ¹Ý»çȸÀû Çൿ µîÀ» µ¿¹ÝÇÑ ¾Æ¹öÁöÀÇ Á¤½Åº´¸®, Àϰü¼º ¾ø´Â ÈÆÀ°, ¾Æµ¿Çдë, ¾î¸Ó´ÏÀÇ ¿ì¿ïÁõ µîÀ» µé ¼ö ÀÖ´Ù. »ý¹°ÇÐÀû ¿äÀÎÀ¸·Î´Â À¯ÀüÀûÀ¸·Î Æ¯Á¤ À¯ÀüÁúº´À» ¾Î´Â È¯ÀÚÀÇ °æ¿ì¿¡ Æø·Â¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ°í, ³ú¼Õ»ó°ú ³úÆÄ ÀÌ»ó, °æ¹ÌÇÑ ½Å°æÇÐÀû ÀÌ»ó, È£¸£¸ó ºÒ±ÕÇü µîµµ ±× ¿øÀÎÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ Àå¾Ö´Â ´ëºÎºÐ ÇнÀÀå¾Ö, ÁÖÀǷ °áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö, ºÒ¾ÈÀå¾Ö, ¾à¹°³²¿ë µî°ú ÇÔ²² ³ªÅ¸³­´Ù. ¹Ì±¹ÀÇ Åë°è¿¡ ÀÇÇϸé 18¼¼ ÀÌÇÏÀÇ ³²¼º 6~16%, ¿©¼º 2~9%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì ÃʵîÇб³ 4~6Çг⠾ÀÌ Áß ³²¾Æ 5%, ¿©¾Æ 2.3%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾ú´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed nerve
    È¥ÇսŰæ
  • mixed order reaction
    È¥ÇÕ¼ø¼­¹ÝÀÀ
  • mixed pineocytoma
    È¥ÇÕ¼Ö¹æ¿ï»ùÁ¾, È¥ÇÕ¼Û°úüÁ¾
  • mixed psychosis
    È¥ÇÕÁ¤½Åº´
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • auditory disorder
    û°¢Àå¾Ö, ³­Ã»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • psychogenic disorder
    Á¤½ÅÅ¿Àå¾Ö, ½ÉÀμºÀå¾Ö
  • reading disorder
    ÀбâÀå¾Ö
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • schizophreniform disorder
    Á¤½ÅºÐ¿­ÇüÀå¾Ö, Á¤½ÅºÐ¿­Çüº´
  • seizure disorder
    ¹ßÀÛÀå¾Ö
  • sexual disorder
    ¼ºÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
  • somatoform disorder
    ½ÅüÇüÀå¾Ö, ½ÅüÇüº´
  • sweating disorder
    ¶¡Àå¾Ö
  • thought disorder
    »ý°¢Àå¾Ö, »ç°íÀå¾Ö
  • vascular disorder
    Ç÷°üÁúȯ, Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mixed psychosis
    È¥ÀçÁ¤½Åº´
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • mixed spicule
    È¥ÇÕħ°ñ
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • mixed germ cell tumor
    È¥ÇÕ¹è¾Æ¼¼Æ÷Á¾¾ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ
  • mixed suspended solid
    È¥ÇÕºÎÀ¯°íÇü¹°
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö, Á¤µ¿º´
  • amnestic disorder
    ±â¾ï»ó½ÇÀå¾Ö
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hallucinogen-induced disorder
    ȯ°¢Á¦ À¯¹ß¼ºÀå¾Ö(º´)(ü³ÊÆð¥ë¯Û¡àõî¡äô)
  • hallucinogen-related disorder
    ȯ°¢Á¦ °ü·ÃÀå¾Ö(º´)(ü³ÊÆð¥Î¼Ö¤î¡äô)
  • hearing disorder
    û·ÂÀå¾Ö
  • hemoglobin disorder
    Ç÷»ö¼ÒÀå¾Ö<--Áúº´>
  • hereditary coagulation disorder
    À¯Àü¼º ÀÀ °íÀå¾Ö.
  • hereditary disorder
    À¯Àü¼ºÀå¾Ö
  • hereditary disorder
    À¯Àü¼º Àå¾Ö<Áúº´>
  • hormonal disorder
    È£¸£¸óÀÌ»ó, ³»ºÐºñÀå¾Ö, È£¸£¸óÀå¾Ö.
  • hyperkinetic disorder
    °ú´Ù¿îµ¿¼º Àå¾Ö, °ú´Ù¿îµ¿º´
  • hypnotic-dependent disorder
    ¼ö¸éÁ¦ÀÇÁ¸Àå¾Ö, ~º´
  • hypoactive sexual desire disorder
    ¼º¿å°¨¼ÒÀå¾Ö, ~º´
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ.
  • identity disorder
    ÁÖü¼º Àå¾Ö
  • immune disorder
    ¸é¿ª Àå¾Ö
  • impulse control disorder
    Ãæµ¿ Á¶ÀýÀå¾Ö, ~º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gland, mixed salivary
    º¹ÇÕħ»ù, È¥ÇÕŸ¾×¼±
  • hearing loss, mixed
    È¥ÇÕ(¼º) ³­Ã»
  • hodgkins disease,mixed cellularity
    È¥ÇÕ¼¼Æ÷Çü
  • leukocyte reaction, mixed
    È¥ÇÕ ¹éÇ÷±¸¹ÝÀÀ
  • lymphocyte culture, mixed
    È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
  • mixed acid
    È¥ÇÕ»ê(ûèùêß«).
  • mixed acid fermentation
    ´ÙÁ¾·ù »ê¹ßÈ¿
  • mixed amputation
    È¥ÇÕ½Ä Àý´Ü(ûèùêãÒôîÓ¨).
  • mixed amputation
    È¥ÇÕ½ÄÀý´Ü(ûèùêãÒôîÓ¨).
  • mixed anesthesia
    È¥ÇÕ¸¶Ãë(¹ý)(¡­Ø«ö­Ûö).
  • mixed anxiety and depression
    È¥À缺 ºÒ¾È¿ì¿ïº´(ûèî¤àõ ÝÕäÌéØê¦Ü»)
  • mixed aphasia
    È¥ÇÕ¼º ½Ç¾îÁõ(¡­àõã÷åÞñø).
  • mixed aphasia
    È¥ÇÕ¼º ½Ç¾îÁõ(¡­àõã÷åÞñø).
  • mixed astigmatism
    È¥ÇÕ³­½Ã
  • mixed bacteria
    È¥ÇÕ¼¼±Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ACLS advanced cardiac life support; Assessment of Children's Language Comprehension
ALD adrenoleukodystrophy; alcoholic liver disease; aldolase; anterior latissimus dorsi; Appraisal of Lan...
ALGOL algorithmic oriented language
ALPS angiolymphoproliferative syndrome; Aphasia Language Performance Scale; attitudinal listening profile...
CCP-SLP Certificate of Clinical Competence in Speech Language Pathology
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SLT Speech and Language Therapists
SLT Speech and language therapy
SLP speech language pathologist
SQL Structured Query Language
UMLS Unified Medical Language System
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾
  • mixed tumor
    È¥ÇÕÁ¾, È¥ÇÕ Á¾¾ç
    µ¿ÀǾî=
  • mixed vaccine
    È¥ÇÕ ¹é½Å
    µÎ Á¾·ù ÀÌ»óÀÇ ¿¹¹æÁ¢Á¾ Àç·á¸¦ È¥ÇÕÇÑ ¹é½Å. È¥ÇÕÇÔÀ¸·Î½á °¢ ¼ººÐÀÇ ¸é¿ª¿ø¼º¿¡ °¨¼ÕÀÌ ¾ø´Â °æ¿ì ÇàÇÏ¿©Áø´Ù. °¡Àå º¸ÆíÀûÀ¸·Î ¾²À̰í ÀÖ´Â °Í¿¡´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½ºÀÇ È¥ÇÕ ¹é½Å, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ AÇü°ú BÇüÀÇ È¥ÇÕ ¹é½Å µîÀÌ ÀÖ´Ù. ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º È¥ÇÕ ¹é½ÅÀº ÀåÆ¼Çª½º±Õ°ú A±Õ ¹× ÆÄ¶óƼǪ½º B±ÕÀ» »ì±ÕÇÏ¿© ÀÏÁ¤ÇÑ ºñÀ²·Î È¥ÇÕÇÑ °ÍÀ¸·Î¼­, ÇÇÇÏ ÁÖ»ç ¶Ç´Â Çdz» ÁÖ»çÇÑ´Ù.
  • mixed venous blood
    È¥ÇÕ Á¤¸ÆÇ÷
  • monogerminal mixed tumor
    ´Ü ¹è¿±¼º È¥ÇÕ Á¾¾ç
  • odontogenic mixed tumor
    Ä¡¿ø È¥ÇÕ Á¾¾ç
  • acquired disorder
    ÈÄõ¼º Àå¾Ö
    ¼±ÃµÀûÀÌ ¾Æ´Ï°í Ãâ»ý ÈÄ Á¤»óÀûÀÎ ¹ßÀ°¿¡ ÀÌ»óÀÌ »ý±â°Å³ª, º¯È­°¡ ¿À°Å³ª, Àå¾Ö°¡ ÀϾ °Í.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö, ÀûÀÀÀå¾Ö º´
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • affective disorder
    Á¤µ¿Àå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö
    °­¹ÚÁõ, ¿Ü»ó ÈÄ ½ºÆ®·¹½ºÀå¾Ö, °øÆ÷Áõ, °øÈ²Àå¾Ö¸¦ Æ÷ÇÔÇÏ´Â ³ÐÀº ÀǹÌÀÇ ½É¸®Àû Áúº´À¸·Î¼­ ºÒ¾È¿¡ ´ëÇÑ ºñÇö½ÇÀûÀ̰í Áö¼ÓÀûÀÎ ´À³¦, ºÒÈ®½Ç¼º, ¹Ì·¡ÀÇ ¿ì·Á³ª À§Çè¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Æ¯Â¡À̸ç, ±äÀå°¨À̳ª ºÒ¾ÈÀ» µ¿¹ÝÇÑ´Ù. À̰ÍÀº ÀûÀÀ ±â´ÉÀÌ Á¦ÇѵǸç, ȯÀÚ¸¦ ¾È½É½Ã۸é Áõ»óÀÌ ¿ÏÈ­µÈ´Ù.
  • articular disorder
    °üÀý Àå¾Ö
  • atypical factitious disorder
    ºñÁ¤Çü °¡À强 Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
mixed discrete-continuous random variable <statistics> A random variable that may assume some values with probabilities and others with probability densities.
For example, in a 35-year-old man with familial polyposis of the colon, the distribution of time until malignant disease occurs consists of a probability that he already has cancer (which would be assigned the waiting time 0), a probability density of developing it in the future and a probability that he will die of some other cause before he develops cancer.
(05 Mar 2000)
mixed disulfide <chemistry> Disulfide which is not symmetric on both sides of the -s-s- linkage; e.g., the disulfide formed between coenzyme A and glutathione or between cysteine and coenzyme A or glutathione.
Synonym: asymmetric disulfide.
(05 Mar 2000)
mixed esotropia <ophthalmology> That type of esotropia in which both accommodative and nonaccommodative factors are present.
(05 Mar 2000)
mixed expired gas <physiology> One or more complete breaths of expired gas coming thoroughly mixed from the dead space and the alveoli.
(05 Mar 2000)
mixed function oxidases <enzyme> Catalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water.
Registry number: EC 1.13.12.
(12 Dec 1998)
mixed gland A gland that contains both serous and mucous secretory units, a gland that is both exocrine and endocrine, e.g., the pancreas.
(05 Mar 2000)
mixed glioma <tumour> A glioma comprised of two or more malignant elements, most frequently astrocytoma and oligodendroglioma.
(05 Mar 2000)
mixed hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
mixed hyperlipidemia mixed hyperlipoproteinaemia familial, type 5 hyperlipidemia
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
mixed hypoglycaemia Hypoglycaemia due to more than one cause.
(05 Mar 2000)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • finger language
    ÁöÈ­
  • flowery language
    ¹Ì»ç¾î±¸
  • formal language
    (¼öÇÐ,³í¸®ÇÐ µî) Çü½Ä¾ð¾î
  • gesture language
    ¸öÁþ ¾ð¾î
  • hand language
    (º¡¾î¸®ÀÇ)¼ÕÁþ¸»;¼öÈ­
  • highlevel language
    °í¼öÁØ ¾ð¾î(ÀÏ»ó¾î¿¡ °¡Àå °¡±î¿î ÇÁ·Î±×·¥¿ë ¾ð¾î)
  • isolating language
    °í¸³¾î(Áß±¹¾î)(cf,AGGKUTINATIVE Languge(±³Âø¾î);INFLECTIONAL LANGUAGE(±¼Àý¾î))
  • language
    ¾ð¾î;±¹¾î;¾î¹ý;¸»;¿å;use ~ to ...¿¡°Ô ¿åÇÏ´Ù
  • language laboratory
    ¾îÇнǽÀ½Ç
  • lip language
    (³ó¾ÆÀÚÀÇ) ½ÃÈ­¹ý 9
  • machine language
    (ÄÄÇ»ÅÍ) ±â°è ¾ð¾î(ÀüÀÚ°è»ê±â¸¦ ÀÛµ¿½Ã۱â À§ÇÑ ¸í·É¾î)
  • object language
    ´ë»ó ¾ð¾î
  • parent language
    Á¶¾î
  • plain language
    ¾ÏÈ£¸¦ »ç¿ëÇÏÁö ¾ÊÀº Ç¥Çö
  • procedure oriented language
    ó¸® Á᫐ ¾ð¾î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á